Researchers still found 'excellent' survival rates for both primary, secondary disease
by mchakra on Fri Jan 25, 2013 06:17 PM
My 67 year old father (Stage IV Colon Cancer Mets to Liver) has finished 1 year on a clinical trial with 5FU + metmab or placebo. he only did 6 months of Oxiliplatin) after he had surgery to remove part of his colon 11/2011. We've learned that his CEA is rising (I know some docs don't care about CEA) and that some of the lesions are growing a bit. The mets to the liver seems to be gone. We've decided to come off this treatment and look for 2nd line treatment.
We are weighing our options between:
1. Folfiri + the new drug Zaltrap
2. Clinical trial in Atlanta: http://www.cancer.gov/clinicaltrials/search/view?cdrid=69592
3. HIPEC surgery
Curious if anyone has used Zaltrap yet?Participated in this 2nd line trial? And/or has done the HIPEC surgery?
We are meeting w/the surgeon Monday at Emory to learn more about it and will make our decision next week. Any and all thoughts would be appreciated.
Big hugs to all of you,
When you track a discussion, you will get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to track this discussion?
If you stop tracking this discussion, you will no longer get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to stop tracking this discussion?
Do you use smart phone apps?
Take our short survey on hospital smart phone apps.
We care about your feedback. Let us know how we can improve your CancerCompass experience.